328 related articles for article (PubMed ID: 22493979)
21. The role of non-coding RNAs in ABC transporters regulation and their clinical implications of multidrug resistance in cancer.
Wang Y; Wang Y; Qin Z; Cai S; Yu L; Hu H; Zeng S
Expert Opin Drug Metab Toxicol; 2021 Mar; 17(3):291-306. PubMed ID: 33544643
[TBL] [Abstract][Full Text] [Related]
22. Mouse ATP-Binding Cassette (ABC) Transporters Conferring Multi-Drug Resistance.
Li S; Zhang W; Yin X; Xing S; Xie HQ; Cao Z; Zhao B
Anticancer Agents Med Chem; 2015; 15(4):423-32. PubMed ID: 25929575
[TBL] [Abstract][Full Text] [Related]
23. The modulation of ABC transporter-mediated multidrug resistance in cancer: a review of the past decade.
Kathawala RJ; Gupta P; Ashby CR; Chen ZS
Drug Resist Updat; 2015 Jan; 18():1-17. PubMed ID: 25554624
[TBL] [Abstract][Full Text] [Related]
24. Reversing multidrug resistance by tyrosine kinase inhibitors.
He M; Wei MJ
Chin J Cancer; 2012 Mar; 31(3):126-33. PubMed ID: 22237041
[TBL] [Abstract][Full Text] [Related]
25. Development of Fourth Generation ABC Inhibitors from Natural Products: A Novel Approach to Overcome Cancer Multidrug Resistance.
Karthikeyan S; Hoti SL
Anticancer Agents Med Chem; 2015; 15(5):605-15. PubMed ID: 25584696
[TBL] [Abstract][Full Text] [Related]
26. Reversal of multidrug resistance by Marsdenia tenacissima and its main active ingredients polyoxypregnanes.
To KKW; Wu X; Yin C; Chai S; Yao S; Kadioglu O; Efferth T; Ye Y; Lin G
J Ethnopharmacol; 2017 May; 203():110-119. PubMed ID: 28363522
[TBL] [Abstract][Full Text] [Related]
27. Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors.
Dallavalle S; Dobričić V; Lazzarato L; Gazzano E; Machuqueiro M; Pajeva I; Tsakovska I; Zidar N; Fruttero R
Drug Resist Updat; 2020 May; 50():100682. PubMed ID: 32087558
[TBL] [Abstract][Full Text] [Related]
28. Reversal effect of FW-04-806, a macrolide dilactone compound, on multidrug resistance mediated by ABCB1 and ABCG2 in vitro and in vivo.
Zhang Z; Ma C; Li P; Wu M; Ye S; Fu L; Xu J
Cell Commun Signal; 2019 Sep; 17(1):110. PubMed ID: 31472682
[TBL] [Abstract][Full Text] [Related]
29. Current Understanding of Interactions between Nanoparticles and ABC Transporters in Cancer Cells.
Yin J; Deng X; Zhang J; Lin J
Curr Med Chem; 2018; 25(42):5930-5944. PubMed ID: 29542407
[TBL] [Abstract][Full Text] [Related]
30. ATP binding cassette transporters and cancer: revisiting their controversial role.
Sharma P; Singh N; Sharma S
Pharmacogenomics; 2021 Dec; 22(18):1211-1235. PubMed ID: 34783261
[TBL] [Abstract][Full Text] [Related]
31. Reversal of ABC drug transporter-mediated multidrug resistance in cancer cells: evaluation of current strategies.
Wu CP; Calcagno AM; Ambudkar SV
Curr Mol Pharmacol; 2008 Jun; 1(2):93-105. PubMed ID: 19079736
[TBL] [Abstract][Full Text] [Related]
32. Strategies for overcoming ABC-transporters-mediated multidrug resistance (MDR) of tumor cells.
Borowski E; Bontemps-Gracz MM; Piwkowska A
Acta Biochim Pol; 2005; 52(3):609-27. PubMed ID: 16175236
[TBL] [Abstract][Full Text] [Related]
33. [Inhibition of ABC-transporter(s)' function in non-small cell lung cancer cells by platinum drugs].
Bogush TA; Konukhova AV; Ravcheeva AB; Zabotina TN; Kadagidze ZG; Bogush EA; Komov DV; Polotskiĭ BE; Laktionov KK; Davydov MI
Antibiot Khimioter; 2003; 48(10):11-5. PubMed ID: 15004974
[TBL] [Abstract][Full Text] [Related]
34. Dacomitinib antagonizes multidrug resistance (MDR) in cancer cells by inhibiting the efflux activity of ABCB1 and ABCG2 transporters.
Fan YF; Zhang W; Zeng L; Lei ZN; Cai CY; Gupta P; Yang DH; Cui Q; Qin ZD; Chen ZS; Trombetta LD
Cancer Lett; 2018 May; 421():186-198. PubMed ID: 29331420
[TBL] [Abstract][Full Text] [Related]
35. ATP-binding cassette (ABC) transporters in cancer: A review of recent updates.
Wang JQ; Wu ZX; Yang Y; Teng QX; Li YD; Lei ZN; Jani KA; Kaushal N; Chen ZS
J Evid Based Med; 2021 Sep; 14(3):232-256. PubMed ID: 34388310
[TBL] [Abstract][Full Text] [Related]
36. Development of inhibitors of ATP-binding cassette drug transporters: present status and challenges.
Shukla S; Wu CP; Ambudkar SV
Expert Opin Drug Metab Toxicol; 2008 Feb; 4(2):205-23. PubMed ID: 18248313
[TBL] [Abstract][Full Text] [Related]
37. The role of ABC transporters in clinical practice.
Leonard GD; Fojo T; Bates SE
Oncologist; 2003; 8(5):411-24. PubMed ID: 14530494
[TBL] [Abstract][Full Text] [Related]
38. Multidrug resistance: molecular mechanisms and clinical relevance.
Ling V
Cancer Chemother Pharmacol; 1997; 40 Suppl():S3-8. PubMed ID: 9272126
[TBL] [Abstract][Full Text] [Related]
39. Immunosuppressors as multidrug resistance reversal agents.
Morjani H; Madoulet C
Methods Mol Biol; 2010; 596():433-46. PubMed ID: 19949935
[TBL] [Abstract][Full Text] [Related]
40. N,N-bis(cyclohexanol)amine aryl esters: the discovery of a new class of highly potent inhibitors of transporter-dependent multidrug resistance (MDR).
Teodori E; Dei S; Martelli C; Scapecchi S
Curr Top Med Chem; 2010; 10(17):1715-31. PubMed ID: 20645921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
